Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
FDA launches the 'PreCheck' program aimed at pharmaceutical facilities that align with national priorities, potentially streamlining the approval process. Meanwhile, Acadia's lupus drug faced setbacks, while MeiraGTx advances its gene therapy portfolio.
Read full storyGet the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.